Join us to create guidelines with the humility of uncertainty.
Deadline to sign up is November 21, 2025.
Join us to create guidelines with the humility of uncertainty.
Deadline to sign up is November 21, 2025.
youtu.be/RuKAKH8A604?...
youtu.be/RuKAKH8A604?...
When guidelines don’t keep up with medicine
"A Blurry Line: Navigating Treatment Decisions When the Guidelines Don't Fit"
#IDSky
academic.oup.com/cid/advance-...
When guidelines don’t keep up with medicine
I just don’t know why we should do a PhD in statistics to understand a trial now
Or maybe am just getting old and grumpy
I just don’t know why we should do a PhD in statistics to understand a trial now
Or maybe am just getting old and grumpy
🆕🔥Systematic Review ( 14 RCTs, N=1322) & Bayesian Meta-Analysis challenged this universally held dogma #idsky
jamanetwork.com/journals/jam...
🆕🔥Systematic Review ( 14 RCTs, N=1322) & Bayesian Meta-Analysis challenged this universally held dogma #idsky
jamanetwork.com/journals/jam...
Link here:
www.bradspellberg.com/oral-antibio...
Link here:
www.bradspellberg.com/oral-antibio...
WikiGuidelines website: www.wikiguidelines.org
Support us to incorporate humility of uncertainty into guidelines!
WikiGuidelines website: www.wikiguidelines.org
Support us to incorporate humility of uncertainty into guidelines!
As said by @bradspellberg.bsky.social 🤩😇
Fabulous conversation!
#IDSky #MedSky #AMSSky
As said by @bradspellberg.bsky.social 🤩😇
Fabulous conversation!
#IDSky #MedSky #AMSSky
www.latimes.com/00000197-c35...
www.latimes.com/00000197-c35...
We have HUGE problems re: guidelines making recommendations & *redefining* entire diseases based on minimal data.
Gov't metrics exacerbate this further.
@bradspellberg.bsky.social @absteward.bsky.social @drtoddlee.bsky.social #EMIMCC
We have HUGE problems re: guidelines making recommendations & *redefining* entire diseases based on minimal data.
Gov't metrics exacerbate this further.
@bradspellberg.bsky.social @absteward.bsky.social @drtoddlee.bsky.social #EMIMCC
Our 🆕🔥 Article at @cidjournal.bsky.social with 🌟s @bradspellberg.bsky.social
Practicing With Intent: How to Teach an Old Dogma New Tricks #IDSky
academic.oup.com/cid/article/...
Our 🆕🔥 Article at @cidjournal.bsky.social with 🌟s @bradspellberg.bsky.social
Practicing With Intent: How to Teach an Old Dogma New Tricks #IDSky
academic.oup.com/cid/article/...
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
@bradspellberg.bsky.social, and we've had a phenomenal team - @abhaydhand.bsky.social, @alejodiaz81.bsky.social, Dr. Ali Meza Vazquez, Neal Fox, and help from many contributors from around the world.
@bradspellberg.bsky.social, and we've had a phenomenal team - @abhaydhand.bsky.social, @alejodiaz81.bsky.social, Dr. Ali Meza Vazquez, Neal Fox, and help from many contributors from around the world.
Deadline to sign up: 6/20/25
New to WikiGuidelines?
Use the link below to complete WikiGuidelines New Participant application. forms.office.com/r/Tyb8R0iM8X
Deadline to sign up: 6/20/25
New to WikiGuidelines?
Use the link below to complete WikiGuidelines New Participant application. forms.office.com/r/Tyb8R0iM8X
www.bradspellberg.com/vaccine-rcts
www.bradspellberg.com/vaccine-rcts
260 trials (1951 to 2025)
2,468,751 trial participants
Possibly the most comprehensive dataset of its kind.
Huge thanks to the team that powered through to this milestone.
@bradspellberg.bsky.social
docs.google.com/spreadsheets/d…
260 trials (1951 to 2025)
2,468,751 trial participants
Possibly the most comprehensive dataset of its kind.
Huge thanks to the team that powered through to this milestone.
@bradspellberg.bsky.social
docs.google.com/spreadsheets/d…
www.bradspellberg.com/shorter-is-b...
www.bradspellberg.com/shorter-is-b...
More to come...
docs.google.com/spreadsheets/d…
@bradspellberg.bsky.social
@apnews.com @statnews.com @nytimes.com
More to come...
docs.google.com/spreadsheets/d…
@bradspellberg.bsky.social
@apnews.com @statnews.com @nytimes.com
The study challenges IDSA guidance which recommend against the use of CAZ for treatment of S.maltophilia
Ceftazidime retains in vivo efficacy against strains of Stenotrophomonas maltophilia for which traditional testing predicts resistance #idsky
journals.asm.org/doi/10.1128/...